April 2023 – Policy & Medicine

PhRMA Submits Comments to USITC Regarding Section 332 Investigation

The Impact of Ending the Public Health Emergency on Telemedicine

CMMI Announces New Pilot Programs

CMS Publishes Initial Guidance Documents For Inflation Rebate Provisions

AMGA Opposes FTC Non-Compete Clause Rule

Former CEO of Drug Distribution Company Sentenced to Prison

DOJ Announces Kickback Settlement with Neurosurgeon and His Fiancée

CMS Faces Tight Timeline to Implement IRA Rules on Part B and Part D Drug Negotiations

The Pill Club Reaches $18 Million California Settlement Over Fraud Allegations

DOJ Withdraws Three Policy Statements Regarding Health Care Antitrust Enforcement